|
Volumn 2, Issue 10, 2001, Pages 593-
|
Vitamin D derivatives convert colon cancer cells
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1,25 DIHYDROXYERGOCALCIFEROL;
BETA CATENIN;
BIOLOGICAL MARKER;
UVOMORULIN;
VITAMIN D DERIVATIVE;
VITAMIN D RECEPTOR;
DRUG DERIVATIVE;
VITAMIN D;
CANCER CELL;
CANCER RESEARCH;
CELL DIFFERENTIATION;
CELL MIGRATION;
CELL TRANSFORMATION;
CLINICAL TRIAL;
COLON CANCER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIETARY INTAKE;
DRUG MECHANISM;
EPITHELIUM CELL;
HUMAN;
HYPERCALCEMIA;
METASTASIS;
NOTE;
ONCOGENE;
PRIORITY JOURNAL;
PROGNOSIS;
PROTECTION;
ARTICLE;
CELL CULTURE;
COLON TUMOR;
PATHOLOGY;
COLONIC NEOPLASMS;
HUMANS;
TUMOR CELLS, CULTURED;
VITAMIN D;
|
EID: 0035475879
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(01)00510-1 Document Type: Note |
Times cited : (2)
|
References (0)
|